Delivery Order SPE2DB20D1100-SPE2DB25FC9K6

Award Date 6/17/25
Potential Completion Date 6/18/25
Potential Value $5.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,843.23 contract is for the supply of Atovaquone-Proguanil 250-100 100s, a malaria prevention medication. The contract has an ultimate completion date of April 3, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Atovaquone-Proguanil 250-100 100s medication. The contract has a firm fixed price of $5,260.71 and a performance period ending on June 25, 2025. The contract is not set aside and was awarded on June 24, 2025. Amerisourcebergen Drug Corp is the prime contractor and holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,996.18 firm fixed-price contract is for the supply of ATOVAQUONE-PROGUANIL 250-100 100S, a generic pharmaceutical product. The contract has an ultimate completion date of September 22, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $7,820.59. The award is for the delivery of Atovaquone-Proguanil 250-100 100s, a pharmaceutical product, with a performance period through May 8, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. (doing business as Amerisourcebergen), to provide Atovaquone-Proguanil 250-100 100S pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The delivery order has a ceiling value of $1,334.60 and a firm fixed price pricing type. The contract is not set aside and has a period of performance through April 15, 2024. Amerisourcebergen Drug Corp holds...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ATOVAQUONE-PROGUANIL 250-100 100S, a generic antimalarial medication. The $12,350.21 firm fixed-price contract has an ultimate completion date of August 19, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Atovaquone-Proguanil 250-100 24S, a pharmaceutical product, and has a ceiling value of $5,540.40. The contract is a firm fixed-price, delivery order type, with a period of performance through November 19, 2024. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567197863 - ATOVAQUONE-PROGUANIL 250-100 100S, a pharmaceutical product, with a ceiling value of $11,671.59 and a completion date of February 10, 2025. The contract is a firm fixed price Delivery Order under an Indefinite Delivery Contract (IDC) vehicle with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,806.72 firm fixed-price contract is for the delivery of Atovaquone-Proguanil 250-100 UD (unit dose) medication, with a completion date of November 17, 2023. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This $11,684.52 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The order is for 4,565,384,970 units of Atovaquone-Proguanil 250-100 100S, a prescription anti-malarial medication. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999 between Amerisourcebergen and DLA Troop Support Medical, which provides a comprehensive range of medical...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FC9K6
    Delivery Order

This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of Atovaquone-Proguanil 250-100 100s, a malaria medication, with a firm fixed price of $5,807.70 and a completion date of June 18, 2025.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This allows the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The current delivery order is not designated as a set-aside contract.

Generated 9/16/25, 10:00 AM